Latest Drug Development Stories
BILLERICA, Mass., May 22, 2015 /PRNewswire/ -- BioScale, Inc., a leading supplier of novel protein measurement technology to accelerate the development of diagnostic and clinical applications,
DUBLIN, May 22, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/3rthk2/latest)
SAN DIEGO, May 20, 2015 /PRNewswire/ -- Cypher Genomics, Inc., a leading genome informatics company, today announced a collaboration with Celgene Corporation to apply Cypher's Coral(TM )technology
CUPERTINO, Calif., May 18, 2015 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it has obtained positive results from a multi-dose Phase 1 clinical trial with an oral
VANCOUVER, BC and MONTRÉAL, May 14, 2015 /CNW/ - The Institute for Research in Immunology and Cancer - Commercialization of Research (IRICoR) at the Université de Montréal (UdeM) and The Centre
-- Initiated Phase 2 for Prevention of C.
First patient dosed in Europe PETACH TIKVA, Israel, May 11, 2015 /PRNewswire/ -- Can-Fite BioPharma Ltd.
HAMBURG, Germany, May 8, 2015 /PRNewswire/ -- bioskin® is excited to announce its participation in the 6(th) AGAH Dermatological Product Development Workshop.
GIA announces the release of a comprehensive global report on Orphan Drugs.
Managing Director of CompassX Group Kyle J.
- A woman chauffeur.
- A woman who operates an automobile.